Clarification sought from Lupin

25 May 2015 Evaluate

The Exchange has sought clarification from Lupin with respect to news article appearing on Financial Express on May 22, 2015 titled ‘Some drugs made by Lupin, DRL & Mylan lose EU approval.’

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2150.25 18.45 (0.87%)
30-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1598.00
Dr. Reddys Lab 1215.70
Cipla 1328.40
Zydus Lifesciences 888.50
Lupin 2150.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×